Position in ARGX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$365,541
+$82,204 QoQ
Shares Held
394
+1.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#334
of 504 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PDS Planning, Inc holds $2,326,019 across 8 Biotechnology names. ARGX ranks #2 (15.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,354 | $672,572 | |
| 2 | ARGX |
Argenx SE
This page
|
394 | $365,541 | |
| 3 | RPRX |
Royalty Pharma plc
|
5,059 | $283,658 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
416 | $259,392 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,128 | $254,963 | |
| 6 | HELP |
Cybin Inc.
|
30,344 | $200,573 | |
| 7 | GMAB |
Genmab A/S
|
7,293 | $200,338 | |
| 8 | RXRX |
Recursion Pharmaceuticals, Inc.
|
24,246 | $88,982 |
All Filings in ARGX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $365,541 | 394 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $283,337 | 388 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $338,061 | 402 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $295,761 | 401 | Shares | Sole | 2025-10-21 | |
| 2025-03-31 | $203,601 | 344 | Shares | Sole | 2025-04-24 | |
| No filing history on record for this holder in this stock. | ||||||